5
Views
1
CrossRef citations to date
0
Altmetric
Original

Genetic Variations in Vascular Endothelial Growth Factor and Endothelial Nitric Oxide Synthase and Their Contributions to Human Disease

Pages 129-140 | Received 01 Jun 2004, Accepted 28 Jun 2004, Published online: 10 Jul 2009

REFERENCES

  • Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 2001; 4: 289–298, [PUBMED], [INFOTRIEVE]
  • Albrecht E W, Stegeman C A, Heeringa P, Henning R H, van Goor H. Protective role of endothelial nitric oxide synthase. J Pathol 2003; 199: 8–17, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Alderton W K, Cooper C E, Knowles R G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593–615, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51: 1635–1639, [PUBMED], [INFOTRIEVE]
  • Bates D O, Cui T G, Doughty J M, Winkler M, Sugiono M, Shields J D, Peat D, Gillatt D, Harper S J. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002; 62: 4123–4131, [PUBMED], [INFOTRIEVE]
  • Bhushan M, McLaughlin B, Weiss J B, Griffiths C E. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol 1999; 141: 1054–1060, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Braverman I M, Sibley J. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 1982; 78: 12–17, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435–439, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Carmeliet P, Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund S L, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall H S, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison K E, Robberecht W, Van Broeckhoven C, Collen D, Andersen P M, Stalmans I, De Smet F, Jansen S, Wang J, Maity S, Kneer P, von der Ohe M, Swillen A, Maes C, Gewillig M, Molin D G, Hellings P, Boetel T, Haardt M, Compernolle V, Plaisance S, Emanuel B, Gittenberger-de Groot A C, Scambler P, Morrow B, Driscol D A, Esguerra C V, Carmeliet G, Behn-Krappa A, Devriendt K, Conway S J. Blood vessels and nerves: common signals, pathways and diseases VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death VEGF: a modifier of the del22q11 (DiGeorge) syndrome?. Nat Rev Genet 2003; 4: 710–720, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Chang K, Baek S H, Seung K B, Kim P J, Ihm S H, Chae J S, Kim J H, Hong S J, Choi K B. The Glu298Asp polymorphism in the endothelial nitric oxide synthase gene is strongly associated with coronary spasm. Coron Artery Dis 2003; 14: 293–299, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Christinger H W, Muller Y A, Berleau L T, Keyt B A, Cunningham B C, Ferrara N, de Vos A M. Crystallization of the receptor binding domain of vascular endothelial growth factor. Proteins 1996; 26: 353–357, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, Thorens B, Scherrer U. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003; 133: 360–363, [PUBMED], [INFOTRIEVE], [CSA]
  • Creamer D, Allen M, Jaggar R, Stevens R, Bicknell R, Barker J. Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor. Arch Dermatol 2002; 138: 791–796, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Detmar M, Brown L F, Claffey K P, Yeo K T, Kocher O, Jackman R W, Berse B, Dvorak H F. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994; 180: 1141–1146, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Dor Y, Djonov V, Abramovitch R, Itin A, Fishman G I, Carmeliet P, Goelman G, Keshet E. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 2002; 21: 1939–1947, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber H P, Kikkawa Y, Miner J H, Quaggin S E. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707–716, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 2002; 29: 10–14, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea K S, Powell-Braxton L, Hillan K J, Moore M W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–442, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Ferrara N, Gerber H P, LeCouter J. The biology of VEGF its receptors. Nat Med 2003; 9: 669–676, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Furchgott R F, Zawadzki J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Gerber H P, Vu T H, Ryan A M, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623–628, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Giordano F J, Gerber H P, Williams S P, VanBruggen N, Bunting S, Ruiz-Lozano P, Gu Y, Nath A K, Huang Y, Hickey R, Dalton N, Peterson K L, Ross J, Jr., Chien K R, Ferrara N. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 2001; 98: 5780–5785, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Granath B, Taylor R R, van Bockxmeer F M, Mamotte C D. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk 2001; 8: 235–241, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521–526, [PUBMED], [INFOTRIEVE], [CSA]
  • Huez I, Bornes S, Bresson D, Creancier L, Prats H. New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 2001; 15: 2197–2210, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Jerome L A, Papaioannou V E. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat Genet 2001; 27: 286–291, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Kajiyama N, Saito Y, Miyamoto Y, Yoshimura M, Nakayama M, Harada M, Kuwahara K, Kishimoto I, Yasue H, Nakao K. Lack of association between T-786– > C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens Res 2000; 23: 561–565, [PUBMED], [INFOTRIEVE], [CSA]
  • Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, Yazaki Y. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999; 33: 933–936, [PUBMED], [INFOTRIEVE], [CSA]
  • Keyt B A, Berleau L T, Nguyen H V, Chen H, Heinsohn H, Vandlen R, Ferrara N. The carboxyl-terminal domain (111–165] of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 1996; 271: 7788–7795, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Keyt B A, Nguyen H V, Berleau L T, Duarte C M, Park J, Chen H, Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 1996; 271: 5638–5646, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Khurana V G, Sohni Y R, Mangrum W I, McClelland R L, O'Kane D J, Meyer F B, Meissner I. Endothelial nitric oxide synthase T-786C single nucleotide polymorphism: a putative genetic marker differentiating small versus large ruptured intracranial aneurysms. Stroke 2003; 34: 2555–2559, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Li B, Fuh G, Meng G, Xin X, Gerritsen M E, Cunningham B, de Vos A M. Receptor-selective variants of human vascular endothelial growth factor: geeration and characterization. J Biol Chem 2000; 275: 29823–29828, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Liu J, Garcia-Cardena G, Sessa W C. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 1996; 35: 13277–13281, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Liu J, Hughes T E, Sessa W C. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol 1997; 137: 1525–1535, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Maes C, Carmeliet P, Moermans K, Stockmans I, Smets N, Collen D, Bouillon R, Carmeliet G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 2002; 111: 61–73, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Mattot V, Moons L, Lupu F, Chernavvsky D, Gomez R A, Collen D, Carmeliet P. Loss of the VEGF(164] and VEGF(188] isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice. J Am Soc Nephrol 2002; 13: 1548–1560, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K. T-786–C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864–2870, [PUBMED], [INFOTRIEVE]
  • Nasreen S, Nabika T, Shibata H, Moriyama H, Yamashita K, Masuda J, Kobayashi S. T-786C polymorphism in endothelial NO synthase gene affects cerebral circulation in smokers: possible gene-environmental interaction. Arterioscler Thromb Vasc Biol 2002; 22: 605–610, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Nielsen H J, Christensen I J, Svendsen M N, Hansen U, Werther K, Brunner N, Petersen L J, Kristensen J K. Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflamm Res 2002; 51: 563–567, [PUBMED], [INFOTRIEVE], [CSA]
  • Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost M R, Sciot R, Bruyninckx F, Hicklin D J, Ince C, Gressens P, Lupu F, Plate K H, Robberecht W, Herbert J M, Collen D, Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131–138, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Poltorak Z, Cohen T, Neufeld G, Gengrinovitch S. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases Vascular endothelial growth factor (VEGF) and its receptors. Herz 2000; 25: 126–129, [PUBMED], [INFOTRIEVE]
  • Raab S, Beck H, Gaumann A, Yuce A, Gerber H P, Plate K, Hammes H P, Ferrara N, Breier G. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 2004; 91: 595–605, [PUBMED], [INFOTRIEVE], [CSA]
  • Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004; 53: 861–864, [PUBMED], [INFOTRIEVE]
  • Reaven G M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607, [PUBMED], [INFOTRIEVE]
  • Rossi G P, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina A C. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 2003; 41: 930–937, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Senger D R, Galli S J, Dvorak A M, Perruzzi C A, Harvey V S, Dvorak H F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983–985, [PUBMED], [INFOTRIEVE]
  • Sharan K, Surrey S, Ballas S, Borowski M, Devoto M, Wang K F, Sandler E, Keller M. Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Haematol 2004; 124: 240–243, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 2000; 66: 2557–2562, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Stalmans I, Lambrechts D, De Smet F, Jansen S, Wang J, Maity S, Kneer P, von der Ohe M, Swillen A, Maes C, Gewillig M, Molin D G, Hellings P, Boetel T, Haardt M, Compernolle V, Dewerchin M, Plaisance S, Vlietinck R, Emanuel B, Gittenberger-de Groot A C, Scambler P, Morrow B, Driscol D A, Moons L, Esguerra C V, Carmeliet G, Behn-Krappa A, Devriendt K, Collen D, Conway S J, Carmeliet P. VEGF: a modifier of the del22q11 (DiGeorge) syndrome?. Nat Med 2003; 9: 173–182, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Stalmans I, Ng Y S, Rohan R, Fruttiger M, Bouche A, Yuce A, Fujisawa H, Hermans B, Shani M, Jansen S, Hicklin D, Anderson D J, Gardiner T, Hammes H P, Moons L, Dewerchin M, Collen D, Carmeliet P, D'Amore P A. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109: 327–336, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Stevens A, Soden J, Brenchley P E, Ralph S, Ray D W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003; 63: 812–816, [PUBMED], [INFOTRIEVE]
  • Tesauro M, Thompson W C, Rogliani P, Qi L, Chaudhary P P, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 2000; 97: 2832–2835, [PUBMED], [INFOTRIEVE], [CSA]
  • Ukkola O, Erkkila P H, Savolainen M J, Kesaniemi Y A. Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med 2001; 249: 451–459, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Via M, Lopez-Alomar A, Valveny N, Gonzalez-Perez E, Bao M, Esteban E, Pinto X, Domingo E, Moral P. Lack of association between eNOS gene polymorphisms and ischemic heart disease in the Spanish population. Am J Med Genet 2003; 116A: 243–248, [CROSSREF]
  • Wang C L, Hsu L A, Ko Y S, Ko Y L, Lee Y H. Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. J Formos Med Assoc 2001; 100: 736–740, [PUBMED], [INFOTRIEVE], [CSA]
  • Wang X L, Sim A S, Badenhop R F, McCredie R M, Wilcken D E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2: 41–45, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Watson C J, Webb N J, Bottomley M J, Brenchley P E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232–1235, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Weston G C, Haviv I, Rogers P A. Microarray analysis of VEGF-responsive genes in myometrial endothelial cells. Mol Hum Reprod 2002; 8: 855–863, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Whittle C, Gillespie K, Harrison R, Mathieson P W, Harper S J. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci (Lond) 1999; 97: 303–312, [CSA]
  • Xia Y P, Li B, Hylton D, Detmar M, Yancopoulos G D, Rudge J S. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003; 102: 161–168, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Yang S, Toy K, Ingle G, Zlot C, Williams P M, Fuh G, Li B, de Vos A, Gerritsen M E. Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors. Arterioscler Thromb Vasc Biol 2002; 22: 1797–1803, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H, Nakao K. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T–786–> C and missense Glu298Asp variants. J Investig Med 2000; 48: 367–374, [PUBMED], [INFOTRIEVE]
  • Yoshimura T, Yoshimura M, Tabata A, Yasue H, Okamura H. The missense Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption. Hum Genet 2001; 108: 181–183, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Young H S, Summers A M, Bhushan M, Brenchley P E, Griffiths C E. Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 2004; 122: 209–215, [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Zanchi A, Moczulski D K, Hanna L S, Wantman M, Warram J H, Krolewski A S. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000; 57: 405–413, [PUBMED], [INFOTRIEVE]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.